aspirin has been researched along with bwa 4c in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achenbach, J; Barzen, S; Brüggerhoff, A; Hofmann, B; Ihlefeld, K; Kretschmer, SB; Proschak, E; Rödl, CB; Stark, H; Steinhilber, D; Vogt, D | 1 |
| Alaoui El Azher, M; Dumarey, C; Havet, N; Singer, M; Touqui, L | 1 |
2 other study(ies) available for aspirin and bwa 4c
| Article | Year |
|---|---|
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.
Topics: 5-Lipoxygenase-Activating Proteins; Aminophenols; Cyclooxygenase 2; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; HeLa Cells; Humans; Molecular Structure; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; U937 Cells | 2014 |
Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages evidence for the eicosanoid-independent pathway.
Topics: Animals; Arachidonic Acid; Aspirin; Benzeneacetamides; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Group II Phospholipases A2; Guinea Pigs; Hydroxamic Acids; Inhibitory Concentration 50; Lipoxygenase; Lipoxygenase Inhibitors; Macrophages, Alveolar; Male; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Triazoles; Tumor Necrosis Factor-alpha | 2000 |